Eli Lilly's diabetes portfolio grows with FDA nod for projected blockbuster drug - MedCity News
Lilly's insulin drug, a new generic Humalog, will be half the price
U.S. FDA flags shortage of Eli Lilly's new diabetes drug Mounjaro | Reuters
Lilly's Diabetes Drug Fuels Wall Street Enthusiasm for Shares - BNN Bloomberg
People with diabetes lost up to 34 pounds taking Eli Lilly drug, company says
Powerful new obesity drug poised to upend weight loss care | DC News Now | Washington, DC
Drugs developed to treat diabetes may offer new approach against Alzheimer's | The Japan Times
Neue Therapieoption bei Diabetes mellitus: Was ist das Besondere an Insulin lispro Lyumjev?
Lilly diabetes drug could bring $10B to diverse blockbuster pipeline – analysts | S&P Global Market Intelligence
Eli Lilly plans to cut insulin prices, expand cost cap for patients | AP News
Eli Lilly Shifts Strategy from More Sales to Better Diabetes Drugs
Drugmaker Eli Lilly Bets on Ozempic-Like Weight Loss Treatment Mounjaro - Bloomberg
Lilly's Mounjaro back in stock amid heightened obesity interest
Tirzepatide drives deep drops in blood sugar and body weight in diabetes phase 3 | Fierce Biotech
lilly: Lilly withered in India's blooming diabetes market. Key deficiency: an India-specific sales pitch. - The Economic Times
Eli Lilly's next-generation obesity drug helped patients lose up to 34 pounds in clinical trial - MarketWatch
Eli Lilly cuts insulin prices up to 70% amid pressure to slash costs - ABC News
Eli Lilly to cut price of insulin drugs by 70% | Financial Times
Lilly's new diabetes drug doubled sales expectations. It may also be used to treat obesity - MarketWatch
Lilly Doesn't Expect to Meet Near-Term Demand for Diabetes Drug | SupplyChainBrain
After Novo's Wegovy supply woes, rival Lilly sees shortages for Mounjaro, Trulicity | Fierce Pharma
The world's top selling diabetes drugs - Pharmaceutical Technology
